Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Insulin administration systems. Possibilities and difficulties].

J L Selam1, G Slama

  • 1Service de Diabétologie, Hôtel-Dieu, Paris.

Presse Medicale (Paris, France : 1983)
|October 10, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes.

Diabetes & metabolism·2011
Same author

Therapeutic alliance and glycaemic control in type 1 diabetes: a pilot study.

Diabetes & metabolism·2010
Same author

Peak-time determination of post-meal glucose excursions in insulin-treated diabetic patients.

Diabetes & metabolism·2010
Same author

Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients.

Diabetes & metabolism·2009
Same author

Benefits of Ophdiat, a telemedical network to screen for diabetic retinopathy: a retrospective study in five reference hospital centres.

Diabetes & metabolism·2009
Same author

Glycaemic index methodology.

Nutrition research reviews·2008
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

New insulin delivery methods like ready-to-use syringes and portable pumps offer improved comfort and effectiveness over conventional therapy. Advanced options such as nasal sprays and artificial pancreas systems are under development for better diabetes management.

Area of Science:

  • Endocrinology
  • Diabetology
  • Biomedical Engineering

Context:

  • Conventional intensive insulin therapy presents limitations in patient comfort and therapeutic effectiveness.
  • Emerging insulin administration technologies aim to overcome these limitations.
  • Diabetes management is continually evolving with advancements in drug delivery and monitoring.

Purpose:

  • To review current and upcoming insulin therapy methods.
  • To evaluate the potential benefits and challenges of novel insulin delivery systems.
  • To provide an overview of advancements in subcutaneous insulin administration, transplantation, and artificial pancreas technology.

Summary:

  • Ready-to-use insulin syringes and portable insulin pumps represent advancements in subcutaneous insulin delivery.

Related Experiment Videos

  • Pancreas and islets transplantation face hurdles related to tissue availability and immunosuppression requirements.
  • Nasal insulin sprays and implantable artificial pancreas systems show promise but require further development in bioavailability, toxicity, and glucose sensing.

    • Impact:

    • Novel insulin delivery systems offer enhanced patient comfort and potentially improved glycemic control.
    • Implantable insulin pumps provide a viable alternative for patients with difficult-to-manage diabetes and high hypoglycemia risk.
    • Continued research into bioavailability, toxicity, and sensor technology is crucial for the widespread adoption of next-generation insulin therapies.